METBLEO 15IU INJECTION

Yes, METBLEO 15IU INJECTION can cause hair loss, although it is not a common side effect. Hair loss typically occurs only in the area where the drug is administered (for example, in the case of intravenous infusion, hair loss may occur only on the scalp). Hair loss is usually temporary, and hair will grow back once treatment is completed.

Yes, METBLEO 15IU INJECTION can be given to children, but the dose and administration frequency may differ from adults. it is used to treat several types of cancers in children, including Hodgkin's lymphoma and germ cell tumors.

METBLEO 15IU INJECTION is rarely used alone to treat cancer. It is typically used in combination with other chemotherapy drugs or radiation therapy as part of a comprehensive treatment plan. The specific treatment plan will depend on the type and stage of cancer being treated.

Yes, METBLEO 15IU INJECTION can cause fertility problems in both men and women. Men may experience decreased sperm count and quality, while women may experience irregular menstrual cycles or early menopause.

Yes, METBLEO 15IU INJECTION can cause skin reactions such as rash or redness at the injection site. In rare cases, it may also cause more severe skin reactions such as Stevens-Johnson syndrome or toxic epidermal necrolysis. Patients should monitor their skin closely while receiving and report any unusual or severe reactions to their healthcare provider.

A healthcare professional typically administers METBLEO 15IU INJECTION in a hospital or clinic setting. However, in some cases, it may be possible for patients to receive this at home through a home health agency.

Yes, METBLEO 15IU INJECTION can cause hearing loss as a side effect, particularly in patients who receive high doses or long-term treatment. Patients receiving should be monitored for signs of hearing loss, such as ringing in the ears, difficulty hearing, or hearing loss.

METBLEO 15IU INJECTION is primarily metabolized by the liver and excreted through the kidneys. Patients with liver or kidney problems may be at increased risk of side effects and should be closely monitored during treatment.

METBLEO 15IU INJECTION is primarily excreted through the kidneys, so patients with kidney problems may be at increased risk of side effects from the drug. However, the dose may be adjusted in patients with kidney problems to reduce this risk.

NULL

Following your healthcare provider's instructions is important if you have been prescribed Bleocel 15IU Injection. Take the medication as prescribed and promptly report any side effects or symptoms to your healthcare provider. Take steps to maintain your overall health, such as eating a balanced diet, getting enough rest, and exercising regularly, as these can help support your body's ability to tolerate medication and recover from treatment. To ensure the safest and most effective treatment, following all safety advisories related to this injection is important. Women of childbearing age should use effective birth control during treatment and afterward, as this medication can harm a developing fetus. Patients with liver or kidney disease may also require lower doses or more frequent monitoring during treatment. Patients should avoid alcohol while taking it, as it can increase the risk of liver toxicity and other side effects. Communicate openly with your healthcare provider about any concerns or questions about your treatment. If you experience serious side effects or medical emergencies, seek medical attention immediately. With careful monitoring and communication, your healthcare provider can help you navigate any challenges or concerns during treatment.

METBLEO 15IU INJECTION is made using BLEOMYCIN.

METBLEO 15IU INJECTION is prescribed for {Oncology} ailments.